Search

everythinglearnresearchcommunity

for

Search:↓

Blocking certain immune signals can reduce skin damage from radiation therapy.

Premature graying of hair is mainly caused by genetics, stress, and environment, with potential treatments being explored.

Androgenetic alopecia is common hair loss due to genetics and hormones, manageable with early treatment.

Increasing zinc intake improved skin and hair symptoms in a rare genetic disorder.

A 22-year-old woman with a rare genetic condition was successfully treated to develop normal female characteristics and regular menstruation.

Female hair transplants are popular for restoring hair in women with genetic hair loss, but they are costly and not suitable for everyone.

Adjusting neurosteroid levels may help reduce alcohol withdrawal symptoms.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

Effective treatments for spinal and bulbar muscular atrophy are not yet available; more research is needed.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

Taking vitamins, minerals, and amino acids can improve hair strength and quality in people with Monilethrix.

Lasers might help regrow hair in people with hair loss due to genetics.

Minoxidil and finasteride are effective for treating hair loss, with dutasteride showing potential but with side effects.

Melasma is a skin condition linked to female hormones, genetics, UV exposure, and certain medications, but not to pituitary, adrenal, or thyroid diseases.

A 15-year-old girl with no menstrual period was diagnosed with a genetic condition that makes her body unable to respond to male hormones, leading to female characteristics despite having male genetic makeup.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Hair transplantation techniques have improved over 12 years, with follicular unit grafting providing more natural results and potential future advances in automation and genetics.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Sustained-release sodium valproate is effective in treating epilepsy, with some side effects influenced by genetics.

Oral zinc therapy is effective for treating acrodermatitis enteropathica.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

Nanocarriers could improve minoxidil delivery for better hair loss treatment.

Nanocarrier systems could improve hair loss treatments by delivering drugs more effectively.

Finasteride may increase stroke risk in people with clotting tendencies.

Vitiligo treatments include JAK inhibitors, UVB phototherapy, and dietary changes, with emotional support being important.

Traditional Chinese Medicine, combined with antiandrogen therapy, could improve treatment and reduce side effects for genetic hair loss.